[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339962-105":59,"doc-detail-339962-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-comprehensive-prognostic-and-immune-infiltration-analysis-of-uba1-in-pan-cancer-a-computational-analysis-and-in-vitro-experiments","A comprehensive prognostic and immune infiltration analysis of UBA1 in pan-cancer - A computational analysis and in vitro experiments","","Ubiquitin like modifier activating enzyme 1 (UBA1) is examined for its immune regulatory role and biological functions across pan-cancer, with attention to haematological tumours including diffuse large B cell lymphoma and acute myeloid leukaemia. The study integrates multi-database computational work—differential expression, clinical staging, prognostic evaluation, and immune infiltration profiling—and then validates UBA1 functions in cell experiments. Results show elevated UBA1 expression in many cancers, with poor prognosis linked to multiple cancer pathways, methylation, phosphorylation, immune infiltration, and immune therapy response. Cell experiments demonstrate UBA1-dependent regulation of cell-cycle progression and apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comprehensive-prognostic-and-immune-infiltration-analysis-of-uba1-in-pan-cancer-a-computational-analysis-and-in-vitro-experiments/339962/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comprehensive-prognostic-and-immune-infiltration-analysis-of-uba1-in-pan-cancer-a-computational-analysis-and-in-vitro-experiments/339962.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about UBA1 in pan-cancer?","Question",{"text":112,"@type":113},"The study evaluates UBA1’s functional mechanism, its role across pan-cancer, and its clinical value specifically in haematological tumours such as DLBCL and AML.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers analyze UBA1 computationally?",{"text":117,"@type":113},"They performed differential expression, clinical/pathological staging analysis, prognosis analysis, and immune analysis using multiple databases.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports UBA1’s role in haematological tumours?",{"text":121,"@type":113},"Cell experiments confirmed that UBA1 can regulate cell-cycle progression and apoptosis in DLBCL and AML cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339962,1790130060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","DOI: 10. 1111/jcmm.70037  \nOR I G I NAL ART I C L E  \nA comprehensive prognostic and immune infiltration analysis of UBA1 in pan-cancer: A computational analysis and in vitro experiments  \nCan Chen1  | Yiwei Li1 | Zhenzhen Chen1 | Pengfei Shi1 | Yun Li2,3  | Shenxian Qian1   \n1Department of Hematology, Affiliated Hangzhou First People's Hospital, West Lake University, School of Medicine, Hangzhou, China  \n2Team of neonatal & infant development, health and nutrition, NDHN. School of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, China  \n3 Kindstar Global Precision Medicine Institute, Wuhan, China  \nCorrespondence  \nShenxian Qian, Department of Hematology, Affiliated Hangzhou First People's Hospital, West Lake University, School of Medicine, Hangzhou, China.  \nEmail: [sxqian1028@zju.edu.cn](sxqian1028@zju.edu.cn)  \nYun Li, Team of neonatal & infant development, health and nutrition, NDHN. School of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, China.  \nEmail: [liyunez@163.com](liyunez@163.com)  \nFunding information  \nZhejiang Province Traditional Chinese medicine science and technology project, Grant/Award Number: 2023ZR122; Hangzhou science and technology Major Project, Grant/Award Number:  \n202004A15; Hangzhou Medical health science and technology Major Project, Grant/Award Number: Z20210039; Zhejiang Provincial Medical and Health Science and Technology Plan Project, Grant/Award Number: 2021ky881  \nAbstract  \nUbiquitin like modifier activating enzyme 1 (UBA1) plays an important role in immune regulation and cellular function. However, the functional mechanism and role of UBA1 in pan-cancer have not been fully elucidated and its value in haematological tumours (diffuse large B cell lymphoma (DLBC/DLBCL) and acute myeloid leukaemia (AML/ LAML)) has not been explored. We conducted a comprehensive analysis of the functional mechanism and role of UBA1 in pan-cancer using multiple databases, including differential expression analysis, clinical pathological staging analysis, prognosis analysis and immune analysis. Then, we confirmed the function of UBA1 in haematological tumours through cell experiments. The results showed that the expression of UBA1 was significantly increased in most cancers and the differential expression of UBA1 was mainly concentrated in digestive tumours, haematological tumours and brain tumours. Moreover, the high expression of UBA1 had poor prognosis in most tumours, which may be related to its involvement in various cancer-related pathways such as cell cycle, as well as its methylation level, protein phosphorylation level, immune cell infiltration and immune therapy response. Cell experiments have confirmed that UBA1 can significantly regulate the cycle progression and apoptosis of DLBCL cells and AML cells. Therefore, UBA1 may be a potential therapeutic target for haematological tumours. In summary, our study not only comprehensively analysed the functional mechanisms and clinical value of UBA1 in pan-cancer, but also validated for the first time the regulatory role of UBA1 in haematological tumours.  \nK E Y WO R D S  \ncancer immunity, Haematological tumours, Pan-cancer, prognosis, UBA1  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s) . Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.  \n1 | INTRODUCTION  \nVacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory somatic (VEXAS) syndrome is a newly discovered disease caused by somatic mutations in the Ubiquitin like modifier activating enzyme 1 (UBA1) gene, leading to refractory autoimmune features, often accompanied by cellular reduction.1 In December 2020, researchers from the National Institutes of Health in the United States firs","cbCaipXpw2jEIcQQ","https://ap.wps.com/l/cbCaipXpw2jEIcQQ","pdf",9310016,17,"English","# Introduction\n## Background: VEXAS syndrome and UBA1\n## Rationale: UBA1 enzymes and cancer biology","[{\"question\":\"What question does the study address about UBA1 in pan-cancer?\",\"answer\":\"The study evaluates UBA1’s functional mechanism, its role across pan-cancer, and its clinical value specifically in haematological tumours such as DLBCL and AML.\"},{\"question\":\"How did the researchers analyze UBA1 computationally?\",\"answer\":\"They performed differential expression, clinical/pathological staging analysis, prognosis analysis, and immune analysis using multiple databases.\"},{\"question\":\"What experimental evidence supports UBA1’s role in haematological tumours?\",\"answer\":\"Cell experiments confirmed that UBA1 can regulate cell-cycle progression and apoptosis in DLBCL and AML cells.\"}]","A comprehensive prognostic and immune infiltration analysis of UBA1 in pan-cancer - A computational analysis and in vitro experiments | PDF",1790033360,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e233aded9784ed7abd83adebbf52670.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d21f7e88c31e4a3c19c0538d53de3e13.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82acb37a6a41f0bc7dbc7b3bf22e38e1.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f874e7452e811867e2ec2c7877dde97c.webp",980,1287]